Anton Ryzhov

Dr. Anton Ryzhov

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2006 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
EPEero Pukkala
Eero Pukkala
AKAusra Kesminiene
Ausra Kesminiene
SPSemion Poliakov
Semion Poliakov
ARAnton Ryzhov
Anton Ryzhov
VDVladimir Drozdovitch
Vladimir Drozdovitch
ECElisabeth Cardis
Elisabeth Cardis
An increase in breast cancer incidence has been reported in areas of Belarus and Ukraine contaminated by the Chernobyl accident and has become an issue of public concern. The authors carried out an ecological epidemiological study to describe the spatial and temporal trends in breast cancer incidence in the most contaminated regions of Belarus and Ukraine, and to evaluate whether increases seen since 1986 correlate to radiation exposure from the Chernobyl accident. The authors investigated the trends through age‐cohort‐period‐region analyses of district‐specific incidence rates of breast cancer for Gomel and Mogilev regions of Belarus and Chernigiv, Kyiv and Zhytomir regions of Ukraine. Dose‐response analyses were based on Poisson regression, using average district‐specific whole body doses accumulated since the accident from external exposure and ingestion of long‐lived radionuclides. The study demonstrated increases in breast cancer incidence in all areas following the Chernobyl accident, reflecting improvements in cancer diagnosis and registration. In addition, a significant 2‐fold increase in risk was observed, during the period 1997–2001, in the most contaminated districts (average cumulative dose of 40.0 mSv or more) compared with the least contaminated districts (relative risk [RR] in Belarus 2.24, 95% confidence interval [CI] 1.51–3.32 and in Ukraine 1.78, 95% CI = 1.08–2.93). The increase, though based on a relatively small number of cases, appeared approximately 10 years after the accident, was highest among women who were younger at the time of exposure and was observed for both localised and metastatic diseases. It is unlikely that this excess could be entirely due to the increased diagnostic activity in these areas.

1 February 2018 in The Lancet Oncology
Verified
Journal Article
Open access
AZAriana Znaor
Ariana Znaor
SESultan Eser
Sultan Eser
HAHoda Anton-Culver
Hoda Anton-Culver
IFIbtihal Fadhil
Ibtihal Fadhil
ARAnton Ryzhov
Anton Ryzhov
FBFreddie Bray
Freddie Bray
The Global Initiative for Cancer Registry Development partnership, led by the International Agency for Research on Cancer (IARC), was established in response to an overwhelming need for high-quality cancer incidence data from low-income and middle-income countries. The IARC Regional Hub for cancer registration in North Africa, Central and West Asia was founded in 2013 to support capacity building for cancer registration in each of the countries in this region. In this Series paper, we advocate the necessity for tailored approaches to cancer registration given the rapidly changing cancer landscape for this region, and the challenges faced at a national level in developing data systems to help support this process given present disparities in resources and health infrastructure. In addition, we provide an overview of the status of cancer surveillance and activities country-by-country, documenting tailored approaches that are informing local cancer-control policy, and potentially curbing the growing cancer burden across the region.

1 April 2020 in Cancer Epidemiology
Verified
Journal Article
Closed access
ARAnton Ryzhov
Anton Ryzhov
FBFreddie Bray
Freddie Bray
JFJacques Ferlay
Jacques Ferlay
ZFZoya Fedorenko
Zoya Fedorenko
LGLiudmyla Goulak
Liudmyla Goulak
AZAriana Znaor
Ariana Znaor

1 June 2018 in European Journal of Cancer
Verified
Journal Article
Closed access
PPParaskevi Panagopoulou
Paraskevi Panagopoulou
Marios K GeorgakisMarios K Georgakis
Marios K Georgakis
MBMargarita Baka
Margarita Baka
Maria MoschoviMaria Moschovi
Maria Moschovi
VPVassilios Papadakis
Vassilios Papadakis
EPEleni Th Petridou
Eleni Th Petridou

18 December 2017 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
MGMarios K. Georgakis
Marios K. Georgakis
NDNick Dessypris
Nick Dessypris
MBMargarita Baka
Margarita Baka
Maria MoschoviMaria Moschovi
Maria Moschovi
VPVassilios Papadakis
Vassilios Papadakis
EPEleni Th. Petridou
Eleni Th. Petridou
Neuroblastoma comprises the most common neoplasm during infancy (first year of life). Our study describes incidence of neuroblastoma in Southern–Eastern Europe (SEE), including – for the first time – the Nationwide Registry for Childhood Hematological Malignancies and Solid Tumors (NARECHEM‐ST)/Greece, compared to the US population, while controlling for human development index (HDI). Age‐adjusted incidence rates (AIR) were calculated for 1,859 childhood (0–14 years) neuroblastoma cases, retrieved from 13 collaborating SEE registries (1990–2016), and were compared to those of SEER/US (N = 3,166; 1990–2012); temporal trends were assessed using Poisson regression and Joinpoint analyses. The overall AIR was significantly lower in SEE (10.1/million) compared to SEER (11.7 per million); the difference was maximum during infancy (43.7 vs. 53.3 per million, respectively), when approximately one‐third of cases were diagnosed. Incidence rates of neuroblastoma at ages <1 and 1–4 years were positively associated with HDI, whereas lower median age at diagnosis was correlated with higher overall AIR. Distribution of primary site and histology was similar in SEE and SEER. Neuroblastoma was slightly more common among males compared to females (male‐to‐female ratio: 1.1), mainly among SEE infants. Incidence trends decreased in infants in Slovenia, Cyprus and SEER and increased in Ukraine and Belarus. The lower incidence in SEE compared to SEER, especially in infants living in low HDI countries possibly indicates a lower level of overdiagnosis in SEE. Hence, increases in incidence rates in infancy noted in some subpopulations should be carefully monitored to avoid the unnecessary costs health impacts of tumors that could potentially spontaneously regress.

1 April 2018 in Cancer Epidemiology
Verified
Journal Article
Closed access
ARAnton Ryzhov
Anton Ryzhov
FBFreddie Bray
Freddie Bray
JFJacques Ferlay
Jacques Ferlay
ZFZoya Fedorenko
Zoya Fedorenko
LGLiudmyla Goulak
Liudmyla Goulak
AZAriana Znaor
Ariana Znaor